Our initial exploration of the oncogenic potential of UBE2D1 in HCC revealed that UBE2D1 is directly regulated by miR-101, influencing DNA damage repair and apoptosis processes, ultimately leading to resistance to both cDDP and 5Fu in HCC cells. Here, UBE2D1 is linked to hepatocellular carcinoma.